Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01485601
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
121
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
MT10109
Sponsor
Medy-Tox